The National Data Bank for Rheumatic Diseases

Clinical and Experimental Rheumatology

Volumn 34, Issue , 2016, Pages 100-101

  Michaud, Kaleb ^a,b  

^a NATIONAL DATA BANK FOR RHEUMATIC DISEASES   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Database; Fibromyalgia; Osteoarthritis; Pharmaco epidemiology; Rheumatoid arthritis

Indexed keywords

ARTICLE; CHIKUNGUNYA; EDUCATION; FIBROMYALGIA; HEALTH PRACTITIONER; HUMAN; INFECTION; NATIONAL PRACTITIONER DATA BANK; PREGNANCY; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; RESEARCH; RHEUMATIC DISEASE; RHEUMATOLOGIST; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; ZIKA VIRUS; FACTUAL DATABASE; HEALTH SERVICES RESEARCH; PROCEDURES; PROGNOSIS; RHEUMATIC DISEASES; RHEUMATOLOGY; TIME FACTOR; UNITED STATES;

ANTIRHEUMATIC AGENT;

ANTIRHEUMATIC AGENTS; DATABASES, FACTUAL; HEALTH SERVICES RESEARCH; HUMANS; PROGNOSIS; RHEUMATIC DISEASES; RHEUMATOLOGY; TIME FACTORS; UNITED STATES;

EID: 85018269187     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. WOLFE F, MICHAUD K: The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank. Rheumatology (Oxford) 2011; 50: 16-24.
2. CLOWSE ME, CHAKRAVARTY E, COSTENBADER KH, CHAMBERS C, MICHAUD K: Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2012; 64: 668-74.
3. ASKEW RL, COOK KF, KEEFE FJ et al.: A PROMIS measure of neuropathic pain quality. Value Health 2016; 19: 623-30.
4. MICHAUD K, WOLFE F, INMAN CJ: Is there a difference in rheumatology patient reported outcomes when measured at home versus the clinic setting? Arthritis Rheum 2012; 61 (Suppl.): S876.
5. SHAHOURI SH, MICHAUD K, MIKULS TR et al.: Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria. Arthritis Rheum 2011; 63: 3204-15.
6. SIEBERTS SK, ZHU F, GARCIA-GARCIA J et al.: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nat Commun 2016; 7: 12460.
7. MICHAUD K, PEDRO S, SCHUMACHER R, WAHBA K, MOTURU S: Use of smartphones in collecting patient reported outcomes: can passively-collected behavior determine rheumatic disease activity? early results from a nation-wide pilot study. Arthritis Rheum 2014; 66 (Suppl. 10): S47.
8. MOVAHEDI M, BEAUCHAMP ME, ABRAHAMOWICZ M et al.: Risk of incident diabetes mellitus associated with the dosage and duration of oral glucocorticoid therapy in patients with rheumatoid arthritis. Arthritis & rheumatology 2016; 68: 1089-98.
9. MICHAUD K, WALLENSTEIN G, WOLFE F: Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: A longitudinal study of 18,485 patients. Arthritis Care Res 2011; 63: 366-72.
10. WOLFE F, MICHAUD K: The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study. Arthritis Res Ther 2010; 12: R35.
11. WOLFE F, MICHAUD K: The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case-control analysis. Arthritis Rheum 2008; 58: 2612-21.
12. NADAREISHVILI Z, MICHAUD K, HALLENBECK JM, WOLFE F: Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum 2008; 59: 1090-6.
13. WOLFE F, MICHAUD K: The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum 2007; 56: 1433-9.
14. FREDERICK WOLFE KM: Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational study. Arthritis Rheum 2007; 56: 2886-95.
15. BENITO-GARCIA E, MICHAUD K, WOLFE F: The effect of low-dose aspirin on the decreased risk of development of dyspepsia and gastrointestinal ulcers associated to cyclooxygenase-2 selective inhibitors. J Rheumatol 2007; 34: 1765-9.